Long‐term remission with ustekinumab in a patient with PAPA syndrome suggests the importance of IL‐12/IL‐23 cytokines in PSTPIP1‐associated inflammatory diseases
Arthritis &Rheumatology, Accepted Article.
Wiley
Wiley
Wiley
Linking Skin and Joint Inflammation in Psoriatic Arthritis through Shared CD8+ T Cell Clones
Objective Psoriatic arthritis (PsA) is an HLA class I–associated inflammatory arthritis that develops in up to 30% of people with
Wiley
Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients With and Without a Family History of Psoriatic Disease
Objective Although up to 45% of patients with psoriatic arthritis (PsA) have a family history of psoriatic disease, it is
Wiley
Genetics of Childhood‐Onset Systemic Lupus Erythematosus
Objective Genome-wide association studies (GWAS) have identified >100 loci for systemic lupus erythematosus (SLE). These loci may also affect age
Wiley
Monocyte‐Derived Macrophages‐Synovial Fibroblasts Crosstalk Unravels Oncostatin Signaling Network as a Driver of Synovitis in Osteoarthritis
Objective Osteoarthritis (OA) is a debilitating joint disease that is characterized by cartilage degradation, synovial inflammation, and pain. Macrophages have
Wiley
Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis
Objective Patients with juvenile idiopathic arthritis (JIA) frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them
Wiley
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden
Objective Vacuoles, E1-ubiquitin–activating enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a progressive systemic autoinflammatory disorder caused by somatic variants in
Wiley
Pharmacodynamic Effects of Litifilimab in Lupus in a Randomized, Placebo‐Controlled Phase 2 Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines
Objective The pharmacodynamic effects of litifilimab on type I interferon (IFN) response and correlations with clinical outcomes were investigated in
Wiley
A randomized, placebo‐controlled trial of hydroxychloroquine in incomplete lupus
Objectives Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete
Wiley
Performance of an Idiopathic Pulmonary Fibrosis Derived Multibiomarker Panel for Rheumatoid Arthritis‐Associated Interstitial Lung Disease
Objective To assess whether a panel of peripheral blood biomarkers associated with idiopathic pulmonary fibrosis (IPF) is also associated with
Wiley
Transition from psoriasis to psoriatic arthritis is characterized by distinct alterations in peripheral blood Tc17, Th17 and CD4+ TEM cells
Objective Cellular mechanisms driving transition from psoriasis to psoriatic arthritis have remained largely elusive. Thus, we investigated changes within the
Wiley
Mesenchymal Stromal Cell Therapy Alleviates Lupus Nephritis Through Inhibiting Caspase‐4/5/11‐mediated Noncanonical Pyroptosis in Macrophages
Background Caspase-4/5/11 mediated noncanonical pyroptosis emerges as a contributing factor in immune responses under pathological conditions. However, its precise role
Wiley
ZBTB20 Regulating Postnatal Articular Cartilage Development and Homeostasis: Implications for Early‐Onset Osteoarthritis
Objective Mutations in ZBTB20, a transcription factor, are linked to epiphyseal dysplasia and articular degeneration in humans. This study investigates
Wiley
Gut Microbiota Typing and Donor Factors Shape Fecal Microbiota Transplantation Response in Psoriatic Arthritis
Arthritis &Rheumatology, Accepted Article.
Wiley
Response to: “Gut Microbiota Typing and Donor Factors Shape Fecal Microbiota Transplantation Response in Psoriatic Arthritis”
Arthritis &Rheumatology, Accepted Article.
Wiley
Less Is More: Hematologic Safety and Sustained Efficacy of a Modified Low‐dose Etoposide Regimen in MAS
Arthritis &Rheumatology, Accepted Article.
Wiley
Successfully treated mandibular osteomyelitis by TNF inhibitor in SAPHO syndrome
Arthritis &Rheumatology, Accepted Article.
Wiley
Reply to Letter to the editor A&R: “Negative” finding supports two‐hit model, by Ronald van Vollenhoven
Arthritis &Rheumatology, Accepted Article.
Wiley
Orchestration of Skin Pathology in Cutaneous Lupus Erythematosus by HLA Class I Down‐Regulated Senescent Epidermal Basal Cells
Objective This study investigates the role of senescent epidermal basal cells in cutaneous lupus erythematosus (CLE) pathogenesis using skin samples
Wiley
Loss of Tripartite Motif–Containing Protein 21 and UVB‐Induced Systemic Inflammation by Regulating DNA‐Sensing Pathways
Objective Patients with systemic lupus erythematosus (SLE) experience photosensitivity, with exposure to UVB light driving lupus flares and triggering symptoms
Wiley
Limitations in targeting Modic type 1 changes with systemic TNF inhibition: comment on the article by Gjefsen et al
Arthritis &Rheumatology, EarlyView.
Wiley
Reflections on the methodological validity and clinical applicability of weight loss‐induced uric acid reduction
Arthritis &Rheumatology, EarlyView.
Wiley
Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis
Rheumatoid arthritis is a complex systemic disorder characterised primarily by articular inflammation and destruction with associated functional loss and reduced
Wiley
Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double‐Blind, Phase 3 Trial in China
Objective Dotinurad is a selective urate reabsorption inhibitor that reduces serum urate levels. We compared the efficacy and safety of
Wiley
ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF‐1 Signaling
Objective Interleukin-17–producing CD4+ Th17 cells contribute to the pathogenesis of autoimmune diseases, including crescentic glomerulonephritis. Although ADAM9 has been reported